Search
Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
Diagnosis Alzheimer's lifestyle research brainhealth dementia

Text to speech

A Late-Stage Alzheimer’s Trial Gave Them Hope—Until It Was Canceled

By | March 22nd, 2019

Jeff Borghoff and his wife Kimberly speak about participating in the Biogen drug trial testing aducanumab, a drug that targets beta-amyloid. The late-stage trial was recently canceled, news that sent participants, their families, researchers and stocks reeling.

[ Next: ‘They Are Still Here, and They Can Still Contribute’: What He Learned From Alzheimer’s at Age 51 ]

One thought on “A Late-Stage Alzheimer’s Trial Gave Them Hope—Until It Was Canceled

  1. Thank you Deborah Kan and Being Patient for allowing Kim and I to tell our story about our clinical trial experience.

Leave a Reply

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.